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 A comparison of the dominant key genes using GEO2R that are transformed 
in ovarian cancer promoting epithelium cell proliferation and cell differentiation
 Using the Gene Expression Omnibus database (GEO), identify four genes 
that are associated with common factors of epithelial ovarian cancer and 
compare them with the ”Gold-standard,” CA125 (MUC16)
I n t r o d u c t i o n: 
Human epithelial ovarian cancer (EOC) is the most lethal of the gynecological malignancies of the female reproductive system1-2
 It is imperative to find a detection or therapeutic strategy that is specific and sensitive enough to accurately detect early-staged ovarian cancer cells when the cancer cell is still small 
and confined to the ovary
 The current standard diagnostic approved by the US FDA is the CA-125 test coupled with the transvaginal ultrasound2-3
 The CA-125 test cannot be categorized as a screening assay for cancer detection in the general population
 The CA-125 test cannot be used as a single diagnostic test to clinically confirm EOC because an increase in CA-125 can be seen in other conditions such as endometriosis and 
ovarian cysts3
 When the CA-125 test is combined with the transvaginal ultrasound (TVU), a predictive value (PPD) of 40% was obtained. A high PPD was achieved in patients with 
advanced stage EOC, where three out of the four tumors displayed in early-stage cancer came back with a normal prognosis9
 Using the GEO2R Gene Expression Omnibus database, data analysis compared samples with differential genes expression under the conditions of risk prediction, depression, 
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Nuclear transport 
factor 2 like 
export factor 1 
[NXT1]4
• Risk factors such as depression can effect the
Neuroendocrine system, which effects the activity
of tumor cells4
• Patients with depressive symptoms show an
increase in transcription factors, such as NXT1,
which also showed an elevation in norepinephrine4
Ninjurin 2 
[NINJ2]5
• Transforming Growth Factor Beta Receptor 3 
[TGFBR2] influences ovarian cancer metastasis by 
the way of cancer-associated fibroblasts (CAFs)5
• Transcriptional profiling of normal ovarian cell 
tissues treated with TGF-β have shown a key CAF 
gene expression, versican (VCAN)5
LIM and Cysteine 
Rich Domains 1 
[LMCD1]6
• When  TGF-β is activated, LMCD1 was one of the 
identified transcriptional factors containing SMAD4 
in promoter regions6
• Increases in LMCD1 regulates cancer cell invasion 
and metastasis8
Neural EGFL like 
2 [NELL2]7
• Expression differs greatly between normal ovarian 
tissues and cancer tissues 
• Nell2 is significantly upregulated in normal     
ovarian tissues
• Nell2 downregulation indicates an ovarian 
adenocarcinoma
 Experimental data analysis using GEO allows the discovery of 
other than MUC16 that are expressed in association with EOC 
 These four revealed genes are not addressed in the literature and 
require further investigation and recognition due to their significant 
differential expression levels in sample comparison studies
 Depression, TGFBR2 signaling disruption, and the cell niche are 
potential confounding factors in epithelial ovarian cancer 
proliferation
 Molecular mechanisms for each EOC factor are significantly 
expressed through four genes 
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